*MONEY TIMES TALK*
*_MAY 15, 2021_*
*Dr. Reddy’s Labs* has received nod from DRDO for its new anti-Covid drug. A big positive for this company. Buy.
*GE Shipping* posted an excellent FY 21 with an EPS at Rs. 62.38 v/s Rs. 13.91 in FY20 and declared 90% dividend. The rising Baltic freight index translates into rising freight rates. A good long term share to add.
*HFCL* posted a stellar Q4 with NP rising exponentially to Rs. 84.67 cr. v/s Rs. 5.78 cr. last year. The management is optimistic on the back of growing demand from Indian and overseas markets. Buy and retain for 2 years.
*An Ahmedabad based analyst recommends to buy BGR Energy Systems, Dhunseri Ventures, Ind-Swift Labs, Loyal Textile Mills, Lahoti Overseas, Rajoo Engineers, Shilp Gravures, Vipul Organics and Vasundhara Rasayan.*
*Interglobe Aviation (Indigo Airlines)* plans to raise Rs. 3000 cr. via QIP. It is one of the fastest growing low-cost carriers in the world and can be bought selectively with strict stop loss limits.
*Neuland Laboratories* posted Q4 profit of Rs. 17 cr. against a loss of Rs. 9.3 cr. in Q4FY20 due focus on complex APIs and the CMS business. The co. will continue this sustainable growth.
*Granules India* posted 38% rise in Q4 NP at Rs. 128 cr. on 33% rise in revenue to Rs. 799 cr. It also made some new launches and more products are in the pipeline. Add.
*Huhtamaki India’s* Q1CY21 PAT fell 41% YoY to Rs. 16.7 cr. from Rs. 27.31 cr. in Q1CY20. Although the packaging industry is faring well, these results are disappointing. Investors advised to exit.
*Linde India’s* Q1CY21 PAT spurts to Rs 303 cr. from Rs. 39.03 cr. in Q1CY20 on the back of frantic oxygen demand in the current Covid-19 pandemic.
*Saregama*, which is into entertainment including regional and Indian films and songs posted 151% higher Q4 NP at Rs. 37 cr. The company expects the performance to continue. Add.
*ITDC Cementation* has won a Rs. 950 cr. order from GoI for roads & bridges, drainage, waste management and sewage plants, etc. A positive for the Company. Add.
Mucomycosis, also called black fungus, threatens patients recovering from Covid as it can cause loss of vision and even death. *Gufic Biosciences*’ Lypobampoterech helps to cure this disease. A big jump is price in its share is imminent. A screaming buy.
Although the near term demand can be under pressure, *Kansai Nerolac* can be a key beneficiary of the recovery in decorative and industrial paints. A good long term bet. Add.
*Navin Fluorine* is confident of notching higher sales and long term contracts in the high value segment. The share price may continue its onward march. Accumulate.
The Union government has approved Rs. 18100 cr. PLI sops to battery manufactures to cut reliance on imported products. *Amararaja Batteries* can be a big beneficiary. Buy.
bs